Stage IVC Squamous Cell Carcinoma of the Larynx Completed Phase 2 Trials for Ixabepilone (DB04845)

IndicationStatusPhase
DBCOND0029837 (Stage IVC Squamous Cell Carcinoma of the Larynx)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00033618Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and NeckTreatment